Skip to main content
. Author manuscript; available in PMC: 2013 Jul 2.
Published in final edited form as: Ann Rheum Dis. 2011 Oct 13;71(2):206–212. doi: 10.1136/ard.2011.153551

Figure 2.

Figure 2

CART decision tree in patients receiving etanercept plus methotrexate with ACR/EULAR remission at 52 or 48 weeks as the outcome variable. Tree nodes of predicted responders, nonresponders, and patients with indeterminate outcomes are identified by borders of gray, black, and diagonal patterns, respectively. ETN, Etanercept; MTX, Methotrexate; SJC, Swollen joint count; TJC, Tender joint count; CRP, C-reactive protein (in mg/L).